Basic information Safety Supplier Related

13,14-DIHYDROPROSTAGLANDIN E1

Basic information Safety Supplier Related

13,14-DIHYDROPROSTAGLANDIN E1 Basic information

Product Name:
13,14-DIHYDROPROSTAGLANDIN E1
Synonyms:
  • PROSTAGLANDIN F1-ALPHA, 6-KETO-
  • 6-KETO-PROSTAGLANDIN F1ALPHA
  • 6-OXO-9ALPHA,11ALPHA,15S-TRIHYDROXY-PROST-13E-EN-1-OIC ACID
  • 6-KETOPROSTAGLANDIN F1A
  • 6-keto Prostaglandin F1α Lipid Maps MS Standard
  • Epoprostenol Related CoMpound A
  • (9α,11α,13e,15s)-9,11,15-trihydroxy-6-oxoprosta-13-en-1-oic acid
  • 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]-6-oxoheptanoic acid
CAS:
58962-34-8
MF:
C20H34O6
MW:
370.48
Mol File:
58962-34-8.mol
More
Less

13,14-DIHYDROPROSTAGLANDIN E1 Chemical Properties

Boiling point:
575.3±50.0 °C(Predicted)
Density 
1.191±0.06 g/cm3(Predicted)
RTECS 
UK8428300
storage temp. 
−20°C
solubility 
ethanol: 10 mg/mL, clear, faintly yellow
pka
4.69±0.10(Predicted)
form 
White to off-white solid.
color 
White to off-white
BRN 
2821925
More
Less

Safety Information

Safety Statements 
22-24/25
WGK Germany 
3
8-10
HS Code 
2937909000

MSDS

More
Less

13,14-DIHYDROPROSTAGLANDIN E1 Usage And Synthesis

Description

6-keto prostaglandin F (6-keto PGF) is the inactive, non-enzymatic hydrolysis product of PGI2. 6-keto PGF serves as a useful marker of PGI2 biosynthesis in vivo. When [3H]-PGI2 is injected into healthy human males, 6.6% of the radioactivity is recovered from urine as [3H]-6-keto PGF.

Uses

6-Ketoprostaglandin F1α is the stable hydrolysis product of prostacyclin (P839060), an eicosanoid which prevents the formation of platelet plugs and an effective vasodilator.

Definition

ChEBI: A prostaglandin Falpha that is prostaglandin F1alpha bearing a keto substituent at the 6-position.

IC 50

Human Endogenous Metabolite

References

[1] PACE-ASCIAK C. Isolation, structure, and biosynthesis of 6-ketoprostaglandin F1.alpha. in the rat stomach[J]. Journal of the American Chemical Society, 1976, 98 8: 2348-2349. DOI: 10.1021/ja00424a065
[2] ROY A. JOHNSON. The chemical structure of prostaglandin X (prostacyclin)[J]. Prostaglandins, 1976, 12 6: Pages 915-928. DOI: 10.1016/0090-6980(76)90126-x
[3] A R BRASH. Metabolic disposition of prostacyclin in humans.[J]. Journal of Pharmacology and Experimental Therapeutics, 1983, 226 1: 78-87.
[4] MALARVIZHI GURUSAMY. Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice.[J]. Journal of Translational Medicine, 2021: 340. DOI: 10.1186/s12967-021-03016-9

13,14-DIHYDROPROSTAGLANDIN E1Supplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Shanghai EFE Biological Technology Co., Ltd.
Tel
021-65675885 18964387627
Email
info@efebio.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Beijing Solarbio Science & Tecnology Co., Ltd.
Tel
17801761073
Email
3193328036@qq.com